Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1184407197
总结
TPMT intermediate metabolizers is not associated with increased likelihood of specific adverse events when treated with azathioprine, mercaptopurine or purine analogues in people with Inflammatory Bowel Diseases as compared to genotype *1/*1.